SFX by Ex Libris Inc.

Title:	Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins
Source:	Science [0036-8075] Xu, Y yr:2011

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Xu, Y. "Homogeneous low-molecular-weight heparins with reversible anticoagulant activity." Nature chemical biology 10.4 (2014): 248-250.
description	2.	Mackman, N. "Triggers, targets and treatments for thrombosis." Nature 451.7181 (2008): 914-8.
description	3.	Chander, A. "Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system." Thrombosis and haemostasis 110.6 (2013): 1180-1188.
description	4.	She, W. "Dendronized heparin−doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy." Biomaterials 34.9 (2013): 2252-2264.
description	5.	Gemma, E. "DMT-MM mediated functionalisation of the non-reducing end of glycosaminoglycans." Chemical communications 26.26 (2007): 2686-8.
description	6.	Piazza, G. "Venous thromboembolism and cancer." Circulation 128.24 (2013): 2614-2618.
description	7.	Liu, J. "Chemoenzymatic synthesis of heparan sulfate and heparin." Natural product reports 31.12 (2014): 1676-1685.
description	8.	Fu, Fuming i. "Structure and Activity of a New Low-Molecular-Weight Heparin Produced by Enzymatic Ultrafiltration." Journal of pharmaceutical sciences 103.5 (2014): 1375-1383.
description	9.	Meng, X. "Regioselective Chemoenzymatic Synthesis of Ganglioside Disialyl Tetrasaccharide Epitopes." Journal of the American Chemical Society 136.14 (2014): 5205-5208.
description	10.	van Rooij, E. "MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles." Nature reviews. Drug discovery 11.11 (2012): 860-872.
description	11.	Davì, G. "Platelet activation and atherothrombosis." New England Journal of Medicine, The 357.24 (2008): 2482-94.
description	12.	"New Cancer Therapy Findings from School of Materials Engineering Discussed (A pH-Sensitive Injectable Nanoparticle Composite Hydrogel for Anticancer Drug Delivery)." Biotech week 535-.
description	13.	Kim, T. "A biotin-guided fluorescent-peptide drug delivery system for cancer treatment." Chemical communications (London. 1996) 50.57 (2014): 7690-7693.
description	14.	Cordula, Carolina R. "On the catalytic mechanism of polysaccharide lyases: evidence of His and Tyr involvement in heparin lysis by heparinase I and the role of Ca2+." Molecular bioSystems 10.1 (2014): 54-64.
description	15.	liu, r. "supramolecular nanoparticles generated by the self-assembly of polyrotaxanes for antitumor drug delivery." International journal of nanomedicine 7.default (2012): 5249-5258.
description	16.	Chang, Y. "Novel water-soluble and pH-responsive anticancer drug nanocarriers: Doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs)." Journal of colloid and interface science 363.1 (2011): 403-409.
description	17.	Ging-Ho, H. "Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery." Biomaterials 32.8 (2011): 2213-2221.
description	18.	Hojo, K. "Solid phase peptide synthesis in water VI: Evaluation of water-soluble coupling reagents for solid phase peptide synthesis in aqueous media." Protein and peptide letters 13.2 (2006): 189-192.
description	19.	Yamaguchi, N. "Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels." Biomacromolecules 6.4 (2005): 1921-1930.
description	20.	Buttermann, Glenn R R. "The effect of spinal steroid injections for degenerative disc disease." The spine journal 4.5 (2004): 495-505.